These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8831731)

  • 1. Mechanism of selective inhibition of human prostaglandin G/H synthase-1 and -2 in intact cells.
    Kargman S; Wong E; Greig GM; Falgueyret JP; Cromlish W; Ethier D; Yergey JA; Riendeau D; Evans JF; Kennedy B; Tagari P; Francis DA; O'Neill GP
    Biochem Pharmacol; 1996 Oct; 52(7):1113-25. PubMed ID: 8831731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs.
    Greig GM; Francis DA; Falgueyret JP; Ouellet M; Percival MD; Roy P; Bayly C; Mancini JA; O'Neill GP
    Mol Pharmacol; 1997 Nov; 52(5):829-38. PubMed ID: 9351974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential inhibition of murine prostaglandin synthase-1 and -2 by nonsteroidal anti-inflammatory drugs using exogenous and endogenous sources of arachidonic acid.
    Chulada PC; Langenbach R
    J Pharmacol Exp Ther; 1997 Feb; 280(2):606-13. PubMed ID: 9023270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The analysis of nonsteroidal antiinflammatory drug selectivity in prostaglandin G/H synthase (PGHS)-null cells.
    Kirtikara K; Swangkul S; Ballou LR
    Inflamm Res; 2001 Jun; 50(6):327-32. PubMed ID: 11475335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the interaction of specific prostaglandin H synthase-2 inhibitors with prostaglandin H synthase-1.
    Burde T; Rimon G
    Eur J Pharmacol; 2002 Oct; 453(2-3):167-73. PubMed ID: 12398900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H(2) synthases by ibuprofen, naproxen, and indomethacin.
    Jaradat MS; Wongsud B; Phornchirasilp S; Rangwala SM; Shams G; Sutton M; Romstedt KJ; Noonan DJ; Feller DR
    Biochem Pharmacol; 2001 Dec; 62(12):1587-95. PubMed ID: 11755111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of arginine 120 of human prostaglandin endoperoxide H synthase-2 in the interaction with fatty acid substrates and inhibitors.
    Rieke CJ; Mulichak AM; Garavito RM; Smith WL
    J Biol Chem; 1999 Jun; 274(24):17109-14. PubMed ID: 10358065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs.
    Laneuville O; Breuer DK; Dewitt DL; Hla T; Funk CD; Smith WL
    J Pharmacol Exp Ther; 1994 Nov; 271(2):927-34. PubMed ID: 7965814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of autocrine inducible prostaglandin H synthase-2 (PGHS-2) in human osteosarcoma cells.
    Wong E; DeLuca C; Boily C; Charleson S; Cromlish W; Denis D; Kargman S; Kennedy BP; Ouellet M; Skorey K; O'Neill GP; Vickers PJ; Riendeau D
    Inflamm Res; 1997 Feb; 46(2):51-9. PubMed ID: 9085144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
    Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PGHS-2 inhibitors, NS-398 and DuP-697, attenuate the inhibition of PGHS-1 by aspirin and indomethacin without altering its activity.
    Rosenstock M; Danon A; Rimon G
    Biochim Biophys Acta; 1999 Aug; 1440(1):127-37. PubMed ID: 10477832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats.
    Schmassmann A; Peskar BM; Stettler C; Netzer P; Stroff T; Flogerzi B; Halter F
    Br J Pharmacol; 1998 Mar; 123(5):795-804. PubMed ID: 9535006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid.
    O'Neill GP; Mancini JA; Kargman S; Yergey J; Kwan MY; Falgueyret JP; Abramovitz M; Kennedy BP; Ouellet M; Cromlish W
    Mol Pharmacol; 1994 Feb; 45(2):245-54. PubMed ID: 8114674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs.
    DeWitt DL; Meade EA; Smith WL
    Am J Med; 1993 Aug; 95(2A):40S-44S. PubMed ID: 8357002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered sensitivity of aspirin-acetylated prostaglandin G/H synthase-2 to inhibition by nonsteroidal anti-inflammatory drugs.
    Mancini JA; Vickers PJ; O'Neill GP; Boily C; Falgueyret JP; Riendeau D
    Mol Pharmacol; 1997 Jan; 51(1):52-60. PubMed ID: 9016346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine 120 of prostaglandin G/H synthase-1 is required for the inhibition by nonsteroidal anti-inflammatory drugs containing a carboxylic acid moiety.
    Mancini JA; Riendeau D; Falgueyret JP; Vickers PJ; O'Neill GP
    J Biol Chem; 1995 Dec; 270(49):29372-7. PubMed ID: 7493972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed release of prostaglandins from arachidonic acid and kinetic changes in prostaglandin H synthase activity on the induction of prostaglandin H synthase-2 after lipopolysaccharide-treatment of RAW264.7 macrophage-like cells.
    Tanaka Y; Takahashi M; Kawaguchi M; Amano F
    Biol Pharm Bull; 1997 Apr; 20(4):322-6. PubMed ID: 9145202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin H synthase-2 inhibitors interfere with prostaglandin H synthase-1 inhibition by nonsteroidal anti-inflammatory drugs.
    Rosenstock M; Danon A; Rubin M; Rimon G
    Eur J Pharmacol; 2001 Jan; 412(1):101-8. PubMed ID: 11166741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of prostaglandin endoperoxide synthase-1 (cyclooxygenase-1) by valerylsalicylic acid.
    Bhattacharyya DK; Lecomte M; Dunn J; Morgans DJ; Smith WL
    Arch Biochem Biophys; 1995 Feb; 317(1):19-24. PubMed ID: 7872783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.